BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Embryo
,
DNA fingerprint
,
Rosiglitazone
,
rs2300478
,
ERBB2
,
Apoptosis
,
Lung cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
RAB-6.1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Cingulate cortex
Pons
Frontal lobe
Parietal lobe
Globus pallidus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Reprogramming nucleolar size by genetic perturbation of the extranuclear Rab GTPases Ypt6 and Ypt32.
Analysis of subcellular localization and function of the yeast Rab6 homologue, Ypt6p, using a novel …
Fission yeast Ryh1 GTPase activates TOR Complex 2 in response to glucose.
RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenviro…
Structural basis of ELKS/Rab6B interaction and its role in vesicle capturing enhanced by liquid-liqu…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study to Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Es…
Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 1
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of M…
Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief …
A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ